Catalyst Wire Dossier Catalyst Wire Dossier

Clevidipine butyrate injectable emulsion

clevidipine butyrate · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Clevidipine butyrate injectable emulsion, covering 2023-03-24 to 2023-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergency [Phase 3]

See pricing